Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effect of Different Adjuvants on the Longevity and Strength of Humoral and Cellular Immune Responses to the HCV Envelope Glycoproteins
Bassel Akache, Lise Deschatelets, Blair A. Harrison, et al.
Vaccines (2019) Vol. 7, Iss. 4, pp. 204-204
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Archaea Biotechnology
Kevin Pfeifer, İpek Ergal, Martin Koller, et al.
Biotechnology Advances (2020) Vol. 47, pp. 107668-107668
Open Access | Times Cited: 112
Immunogenic and efficacious SARS-CoV-2 vaccine based on resistin-trimerized spike antigen SmT1 and SLA archaeosome adjuvant
Bassel Akache, Tyler M. Renner, Anh Tran, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 43
Ether lipids from archaeas in nano-drug delivery and vaccination
Eder Lilia Romero, María José Morilla
International Journal of Pharmaceutics (2023) Vol. 634, pp. 122632-122632
Closed Access | Times Cited: 15
Hepatitis C virus vaccine design: focus on the humoral immune response
Daniel Sepúlveda‐Crespo, Salvador Resino, Isidoro Martínez
Journal of Biomedical Science (2020) Vol. 27, Iss. 1
Open Access | Times Cited: 35
Immuno-Informatics Analysis of Pakistan-Based HCV Subtype-3a for Chimeric Polypeptide Vaccine Design
Sajjad Ahmad, Farah Shahid, Muhammad Tahir ul Qamar, et al.
Vaccines (2021) Vol. 9, Iss. 3, pp. 293-293
Open Access | Times Cited: 29
Intranasal administration of unadjuvanted SARS‐CoV‐2 spike antigen boosts antigen‐specific immune responses induced by parenteral protein subunit vaccine prime in mice and hamsters
Gerard Agbayani, Bassel Akache, Tyler M. Renner, et al.
European Journal of Immunology (2024) Vol. 54, Iss. 6
Open Access | Times Cited: 3
Inactivated whole hepatitis C virus vaccine employing a licensed adjuvant elicits cross-genotype neutralizing antibodies in mice
Anne Finne Pihl, Shan Feng, Anna Offersgaard, et al.
Journal of Hepatology (2022) Vol. 76, Iss. 5, pp. 1051-1061
Open Access | Times Cited: 15
Archaeosomes and Gas Vesicles as Tools for Vaccine Development
Natalia Adamiak, Krzysztof Krawczyk, Camille Locht, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 19
Inactivated genotype 1a, 2a and 3a HCV vaccine candidates induced broadly neutralising antibodies in mice
Garazi Peña Alzua, Anne Finne Pihl, Anna Offersgaard, et al.
Gut (2022) Vol. 72, Iss. 3, pp. 560-572
Open Access | Times Cited: 12
Mechanistic insight into the induction of cellular immune responses by encapsulated and admixed archaeosome-based vaccine formulations
Gerard Agbayani, Yimei Jia, Bassel Akache, et al.
Human Vaccines & Immunotherapeutics (2020) Vol. 16, Iss. 9, pp. 2183-2195
Open Access | Times Cited: 18
Innate Immune Response against Hepatitis C Virus: Targets for Vaccine Adjuvants
Daniel Sepúlveda‐Crespo, Salvador Resino, Isidoro Martínez
Vaccines (2020) Vol. 8, Iss. 2, pp. 313-313
Open Access | Times Cited: 17
Adjuvanted Schistosoma mansoni-Cathepsin B With Sulfated Lactosyl Archaeol Archaeosomes or AddaVax™ Provides Protection in a Pre-Clinical Schistosomiasis Model
Dilhan J. Perera, Adam S. Hassan, Yimei Jia, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 17
Adjuvants: Engineering Protective Immune Responses in Human and Veterinary Vaccines
Bassel Akache, Felicity C. Stark, Gerard Agbayani, et al.
Methods in molecular biology (2021), pp. 179-231
Closed Access | Times Cited: 15
Characterization of Systemic and Mucosal Humoral Immune Responses to an Adjuvanted Intranasal SARS-CoV-2 Protein Subunit Vaccine Candidate in Mice
Mariam Maltseva, Yannick Galipeau, Tyler M. Renner, et al.
Vaccines (2022) Vol. 11, Iss. 1, pp. 30-30
Open Access | Times Cited: 10
Sulfated Lactosyl Archaeol Archaeosome-Adjuvanted Vaccine Formulations Targeting Rabbit Hemorrhagic Disease Virus Are Immunogenic and Efficacious
Bassel Akache, Andrew J. Read, Renu Dudani, et al.
Vaccines (2023) Vol. 11, Iss. 6, pp. 1043-1043
Open Access | Times Cited: 6
The Synergistic Effects of Sulfated Lactosyl Archaeol Archaeosomes When Combined with Different Adjuvants in a Murine Model
Yimei Jia, Bassel Akache, Gerard Agbayani, et al.
Pharmaceutics (2021) Vol. 13, Iss. 2, pp. 205-205
Open Access | Times Cited: 12
Evaluation of Adjuvant Activity and Bio-Distribution of Archaeosomes Prepared Using Microfluidic Technology
Yimei Jia, Gerard Agbayani, Vandana Chandan, et al.
Pharmaceutics (2022) Vol. 14, Iss. 11, pp. 2291-2291
Open Access | Times Cited: 8
In Silico Prophage Analysis of Halobacterium salinarum ATCC 33170
Danielle L. Peters, Bassel Akache, Wangxue Chen, et al.
Applied Microbiology (2024) Vol. 4, Iss. 2, pp. 607-619
Open Access | Times Cited: 1
Update on Hepatitis C Vaccine: Results and Challenges
Anna Rosa Garbuglia, Silvia Pauciullo, Verdiana Zulian, et al.
Viruses (2024) Vol. 16, Iss. 8, pp. 1337-1337
Open Access | Times Cited: 1
Sulfated Lactosyl Archaeol Archaeosomes Synergize with Poly(I:C) to Enhance the Immunogenicity and Efficacy of a Synthetic Long Peptide-Based Vaccine in a Melanoma Tumor Model
Bassel Akache, Gerard Agbayani, Felicity C. Stark, et al.
Pharmaceutics (2021) Vol. 13, Iss. 2, pp. 257-257
Open Access | Times Cited: 10
Two-component vaccine consisting of virus-like particles displaying hepatitis C virus envelope protein 2 oligomers
Jannick Prentoe, Christoph M. Janitzek, Rodrigo Velázquez‐Moctezuma, et al.
npj Vaccines (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 6
Revisiting the Elusive Hepatitis C Vaccine
Stephen Todryk, Margaret F. Bassendine, Simon H. Bridge
Vaccines (2021) Vol. 9, Iss. 2, pp. 114-114
Open Access | Times Cited: 5
The next generation of HCV vaccines: a focus on novel adjuvant development
Kimia Kardani, Seyed Mehdi Sadat, Mona Kardani, et al.
Expert Review of Vaccines (2021) Vol. 20, Iss. 7, pp. 839-855
Closed Access | Times Cited: 5
Comparison of the oncolytic activity of a replication‐competent and a replication‐deficient herpes simplex virus 1
Georg Lindner, Annika Walter, Clara Luzia Magnus, et al.
Immunology (2024) Vol. 172, Iss. 2, pp. 279-294
Open Access
Functionalized Archaeosomes for Cancer Therapy
Farzaneh Jabbari, Babak Akbari, Lobat Tayebi
Elsevier eBooks (2024), pp. 181-195
Closed Access
Page 1 - Next Page

Scroll to top